Skip to main content
main-content

Rheumatology

Editor's pick

ACR/NPF guidelines for the treatment of PsA published

Guidelines

The American College of Rheumatology and the National Psoriasis Foundation have issued evidence-based guidelines for the pharmacologic and nonpharmacologic treatment of active psoriatic arthritis.

14-12-2018 | Rheumatology | News | Article

Support for abatacept–methotrexate combination therapy in RA patients

Adding abatacept to methotrexate improves disease activity and reduces structural progression among ACPA-positive rheumatoid arthritis patients with early erosion, Japanese researchers report.

Source:

RMD Open 2018; 4: e000813

13-12-2018 | Rheumatology | News | Article

Mortality predictors identified in patients with giant cell arteritis

Patients with large vessel involvement when diagnosed with biopsy-confirmed giant cell arteritis have a substantially increased risk of death relative to patients with no large vessel involvement, Italian researchers report.

Source:

Rheumatology 2018; doi:10.1093/rheumatology/key325

12-12-2018 | Rheumatology | News | Article

Hepatotoxicity reassurance for febuxostat-treated patients with gout and fatty liver disease

Results of an observational study provide preliminary evidence suggesting that patients with gout and fatty liver disease who are treated with febuxostat do not have an elevated risk for hepatotoxicity.

Source:

J Rheumatol 2018; doi:10.3899/jrheum.180761

06-12-2018 | Rheumatology | News | Article

Rituximab may delay RA onset in at-risk individuals

Findings from the PRAIRI trial suggest that a single infusion of the B-cell directed agent rituximab could delay the development of rheumatoid arthritis among individuals positive for anti-citrullinated peptide antibodies and rheumatoid factor.

Source:

Ann Rheum Dis 2018; doi:10.1136/annrheumdis-2017-212763

Twitter Icon Follow medwireNews

Click here
image credits